Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

Castres, FR (1978 - 1980)
Milano, IT (1981)
Milan, IT (1976 - 1991)

Company Filing History:

Recordati S.a. Chemical and Pharmaceutical Company

Prodotti Formeti S.r.l.

patent

6. 1 out of 13

Istituto De Angeli S.p.a.

patents

7. 3 out of 832,718

Other

patents

Years Active: 1976-1991

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5019579 - Pharmaceutical compositions containing dextrorphan for intranasal (1991-05-28),

2. 4774325 - New 8-substituted nucleoside and purine derivatives, the process for the (1988-09-27),

3. 4550115 - Certain piperidino-lower-alkylene esters of (1985-10-29),

4. 4507308 - Analgesically or anti-inflammatory effective 4-quinolyl anthranilic acid (1985-03-26),

5. 4495199 - Dioxolanic amine with pharmacological activity, its method of (1985-01-22),

6. 4246271 - 4-Phenyl-2-thiazolyl-oxamates useful in the treatment of asthma (1981-01-20),

7. 4243679 - S-(3-Methyl-2-butenyl)cysteine (1981-01-06),

8. 4225610 - Immunoactivators derived from amino thiazoles (1980-09-30),

9. 4192883 - Amides of pyrrolidinoethylamine which can be used in lung therapy (1980-03-11),

10. 4122199 - Amides of pyrrolidinoethylamine which can be used in treatment of coughs (1978-10-24),

11. 3952108 - Scopolamine derivatives for treating ulcers and spasms (1976-04-20),

Title: Silvano Casadio: Innovator in Pharmaceutical Compositions

Introduction

Silvano Casadio is a notable inventor based in Milan, Italy, recognized for his contributions to the field of pharmaceuticals. With a total of 11 patents to his name, he has made significant advancements in drug formulations and therapeutic applications.

Latest Patents

Among his latest patents, Casadio has developed pharmaceutical compositions containing dextrorphan for intranasal administration. This invention aims to provide a systemic therapeutic response due to its antitussis action in warm-blooded animals. The composition is characterized by containing a therapeutically efficacious amount of salified dextrorphan and a pharmaceutically non-toxic excipient suitable for intranasal use. Additionally, he has created new 8-substituted nucleoside and purine derivatives, which exhibit antihyperlipaemic activity. These compounds are defined by a specific general formula, where various substituents can be present, enhancing their therapeutic potential.

Career Highlights

Throughout his career, Silvano Casadio has worked with prominent companies, including Pierre Fabre S.A. His work in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of new therapeutic agents.

Collaborations

Casadio has collaborated with notable professionals in the field, including Jean-Pierre Tarayre and Henri Cousse. These partnerships have facilitated the exchange of ideas and fostered advancements in pharmaceutical research.

Conclusion

Silvano Casadio's innovative work in pharmaceutical compositions and his collaborations with esteemed colleagues highlight his significant impact on the industry. His contributions continue to pave the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.